Patient Square Capital LP Portfolio Holdings
Patient Square Capital LP
- $215 Billion
- Q2 2024
Patient Square Capital LP has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $215 Billion distributed in 2 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $129B and Liquidia Corp with a value of $86.2B.
Examining the 13F form we can see an decrease of $19.4B in the current position value, from $235B to 215B.
Patient Square Capital LP is based out at Menlo Park, CA
Below you can find more details about Patient Square Capital LP portfolio as well as his latest detailed transactions.